Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Sep;44(3):472–475. doi: 10.1038/bjc.1981.209

A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro.

J R Johnson, C H Ford, C E Newman, C S Woodhouse, G F Rowland, R G Simmonds
PMCID: PMC2010775  PMID: 7284242

Full text

PDF
472

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Conrad R. A., Cullinan G. J., Gerzon K., Poore G. A. Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates. J Med Chem. 1979 Apr;22(4):391–400. doi: 10.1021/jm00190a008. [DOI] [PubMed] [Google Scholar]
  2. Dykes P. W., Hine K. R., Bradwell A. R., Blackburn J. C., Reeder T. A., Drolc Z., Booth S. N. Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen. Br Med J. 1980 Jan 26;280(6209):220–222. doi: 10.1136/bmj.280.6209.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ghose T., Blair A. H. Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects. J Natl Cancer Inst. 1978 Sep;61(3):657–676. [PubMed] [Google Scholar]
  4. Ghose T., Norvell S. T., Guclu A., Macdonald A. S. Immunochemotherapy of human malignant melanoma with chlorambucil-carrying antibody. Eur J Cancer. 1975 May;11(5):321–326. doi: 10.1016/0014-2964(75)90059-6. [DOI] [PubMed] [Google Scholar]
  5. Goldenberg D. M., DeLand F., Kim E., Bennett S., Primus F. J., van Nagell J. R., Jr, Estes N., DeSimone P., Rayburn P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med. 1978 Jun 22;298(25):1384–1386. doi: 10.1056/NEJM197806222982503. [DOI] [PubMed] [Google Scholar]
  6. Lee F. H., Hwang K. M. Antibodies as specific carriers for chemotherapeutic agents. Cancer Chemother Pharmacol. 1979;3(1):17–24. doi: 10.1007/BF00254415. [DOI] [PubMed] [Google Scholar]
  7. Mach J. P., Carrel S., Forni M., Ritschard J., Donath A., Alberto P. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. N Engl J Med. 1980 Jul 3;303(1):5–10. doi: 10.1056/NEJM198007033030102. [DOI] [PubMed] [Google Scholar]
  8. Nadler L. M., Stashenko P., Hardy R., Kaplan W. D., Button L. N., Kufe D. W., Antman K. H., Schlossman S. F. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 1980 Sep;40(9):3147–3154. [PubMed] [Google Scholar]
  9. Newman C. E., Ford C. H. Antibody-drug synergism: An assessment of specific passive immunotherapy in bronchial carcinoma. Lancet. 1977 Jul 23;2(8030):163–166. doi: 10.1016/s0140-6736(77)90180-5. [DOI] [PubMed] [Google Scholar]
  10. Smith G., Nicklin S. [3H]Uridine uptake by target monolayers as a terminal label in an in vitro cell-mediated cytotoxicity assay. J Immunol Methods. 1979;25(3):265–274. doi: 10.1016/0022-1759(79)90114-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES